A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + Ribavirin
Public ClinicalTrials.gov record NCT00087568. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-label, Multicenter, Efficacy and Safety Study of Pegasys® Plus Ribavirin in Patients With Chronic HCV Infection Who Are Unable to Tolerate or Who Do Not Respond to 12 Weeks of Therapy With PEGIntron ® Plus Ribavirin
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the efficacy, safety and tolerability of PEGASYS plus ribavirin in patients with CHC who could not tolerate or were not responsive to 12 weeks of therapy with PEG-Intron plus ribavirin. The anticipated time on study treatment is 1-2 years, and the target sample size is \>100 individuals.
Study identification
- NCT ID
- NCT00087568
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 57 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2002
- Primary completion
- Feb 28, 2006
- Completion
- Feb 28, 2006
- Last update posted
- Jun 7, 2016
2003 – 2006
United States locations
- U.S. sites
- 25
- U.S. states
- 13
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Bakersfield | California | 93301 | — |
| Not listed | Pasadena | California | 91105 | — |
| Not listed | San Diego | California | 92123 | — |
| Not listed | San Mateo | California | 94403 | — |
| Not listed | Bradenton | Florida | 34209 | — |
| Not listed | Miami | Florida | 33136-1051 | — |
| Not listed | Orlando | Florida | 32806 | — |
| Not listed | Austell | Georgia | 30106 | — |
| Not listed | Annapolis | Maryland | 21401 | — |
| Not listed | Baltimore | Maryland | 21229 | — |
| Not listed | Boston | Massachusetts | 02114 | — |
| Not listed | Kansas City | Missouri | 64131 | — |
| Not listed | Bayside | New York | 11358 | — |
| Not listed | Brooklyn | New York | 11219 | — |
| Not listed | Manhasset | New York | 11030 | — |
| Not listed | New York | New York | 10032 | — |
| Not listed | Valhalla | New York | 10595 | — |
| Not listed | Statesville | North Carolina | 28677 | — |
| Not listed | Cincinnati | Ohio | 45219 | — |
| Not listed | Knoxville | Tennessee | 37920 | — |
| Not listed | Memphis | Tennessee | 38120 | — |
| Not listed | Houston | Texas | 77054 | — |
| Not listed | Fairfax | Virginia | 22031 | — |
| Not listed | Richmond | Virginia | 23298 | — |
| Not listed | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00087568, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 7, 2016 · Synced Sep 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00087568 live on ClinicalTrials.gov.